948351-23-3

Basic information

• Product Name: 1-(4-bromo-3-fluoro-benzyl)-5,7-diethyl-1H-[1,6]naphthyridin-2-one
• Synonyms: 1-(4-bromo-3-fluoro-benzyl)-5,7-diethyl-1H-[1,6]naphthyridin-2-one
• CAS NO: 948351-23-3
• Molecular Weight: 389.267
• Mol File: 948351-23-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1-(4-bromo-3-fluoro-benzyl)-5,7-diethyl-1H-[1,6]naphthyridin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-bromo-3-fluoro-benzyl)-5,7-diethyl-1H-[1,6]naphthyridin-2-one(948351-23-3)
• EPA Substance Registry System: 1-(4-bromo-3-fluoro-benzyl)-5,7-diethyl-1H-[1,6]naphthyridin-2-one(948351-23-3)

Safety Data

• Hazardous Substances Data: 948351-23-3(Hazardous Substances Data)

Upstream product

• 127425-73-4 1-bromo-4-(bromomethyl)-2-fluorobenzene 
• 146720-18-5 5,7-diethyl-[1,6]naphthyridin-2(1H)-one 

Downstream Products

• 948351-22-2 3-[4-(5,7-diethyl-2-oxo-2H-[1,6]naphthyridin-1-ylmethyl)-2-fluoro-phenyl]-5-methyl-thiophene-2-sulfonic acid (4,5-dimethyl-isoxazol-3-yl)-(2-methoxy-ethoxymethyl)-amide 

Relevant articles and documents

NOVEL DUAL ACTION RECEPTORS ANTAGONISTS (DARA) AT THE AT1 AND ETA RECEPTORS

The present invention relates to new compounds of the formula [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, and R31 are as specified herein. The invention also relates to a method for preparation thereof, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the above-mentioned compounds and combinations for the preparation of a medicament for treating hypertension of different kinds, alleviating organ damage of different kinds, treating or preventing diabetic nephropathy, treating endothelin and angiotensin mediated disorders, and treating prostate cancer.